Malaria Chemoprevention, Though Effective, Presents Risk Of Antibiotic Resistance
New York Times: Malaria Prevention, With Both Reward and Risk
Amy Maxmen, science journalist
“…With a limited lifetime, chemoprevention is not an ideal solution for malaria. But the situation is desperate. Malaria remains the No. 1 killer in several countries, and a vaccine that reliably and permanently prevents the disease may be more than a decade away from the market. … Despite its flaws, chemoprevention could prevent 8.8 million cases of malaria and 80,000 deaths annually — but right now, it lacks the political support to fund and carry it out to the full extent…” (6/25).